Program Spending to Increase Adherence: South African Cervical Cancer Screening
暂无分享,去创建一个
[1] M. Stirratt,et al. Adherence to biomedical HIV prevention methods: Considerations drawn from HIV treatment adherence research , 2008, Current HIV/AIDS reports.
[2] J. Franks,et al. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] K. Abba,et al. Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. , 2008, The Cochrane database of systematic reviews.
[4] Vikram Patel,et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care , 2008, The Lancet.
[5] X. Castellsagué,et al. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. , 2008, Vaccine.
[6] D. van Rensburg,et al. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. , 2008, Health policy and planning.
[7] S. van Dulmen,et al. Patient adherence to medical treatment: a review of reviews , 2007, BMC Health Services Research.
[8] L. Denny. Cervical Cancer: The South African Perspective , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[9] J. Dillner,et al. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. , 2006, Vaccine.
[10] Michael Quinn,et al. Chapter 8: Screening for cervical cancer in developing countries. , 2006, Vaccine.
[11] F. Bray,et al. Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.
[12] J. T. Cox,et al. Chapter 7: Achievements and limitations of cervical cytology screening. , 2006, Vaccine.
[13] D. Harper,et al. Chapter 13: Current findings from prophylactic HPV vaccine trials. , 2006, Vaccine.
[14] Sue J Goldie,et al. Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.
[15] Thomas C Wright,et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. , 2005, JAMA.
[16] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[17] Irina Cleemput,et al. Economic implications of non-compliance in health care , 2002, The Lancet.
[18] T. Wright,et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.
[19] P. Garner,et al. Interventions for promoting adherence to tuberculosis management. , 2000, The Cochrane database of systematic reviews.
[20] J. Mandelblatt,et al. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening. , 2000, Preventive medicine.
[21] Judith A. Hall,et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. , 1998, Medical care.
[22] A. Jemal,et al. Global Cancer Statistics , 2011 .
[23] D. Harper,et al. Current findings from prophylactic HPV vaccine trials , 2006 .
[24] L. Denny. Cervical cancer: the South African perspective. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[25] F. Bray,et al. The burden of HPV-related cancers , 2006 .
[26] J. Singh. Clinical Trial Results , 2006 .
[27] E. Denny,et al. Cost Effectiveness and Resource Allocation Open Access the Costs of Reducing Loss to Follow-up in South African Cervical Cancer Screening , 2005 .
[28] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.